The Immigrant Approach To Biotech Formation

By Matthew Pillar, Editor, Bioprocess Online

Avak Kahvejian, Ph.D., joined Flagship Pioneering in 2011, during what he calls the company’s transitionary phase from venture capital to venture creation. The model was simple: Rather than simply fund biotech startups, it would bring those startups’ entrepreneurs, tech, and investors together under one roof to ideate, invent, and conceptualize companies in-house.